thesisxellia corporate presentationShare on FacebookShare on Twitter161IMAGESXellia Pharmaceuticals Receives US FDA Approval for Premixed Vancomycin InjectionNovo A/S acquires Xellia Pharmaceuticals for US$ 700 millionXellia Pharmaceuticals becomes member of Medicines for Europexellia corporate presentation3746 xellia 2015 annual report aw low by Catharine Snellxellia corporate presentation
IMAGES